Panevėžio burnos chirurgijos centras, UAB - financials and debts
Company age: 16 y. 0 mo.
Panevėžio burnos chirurgijos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,311,541 | 1,497,145 | 1,615,006 | 2,103,871 | 2,082,200 | 2,014,239 | 2,126,342 | 2,544,545 |
| Profit before tax | 379,668 | 619,635 | 649,047 | 774,833 | 438,895 | 23,153 | 181,305 | 288,113 |
| Net profit | 329,485 | 552,998 | 557,070 | 666,783 | 379,048 | 2,609 | 158,347 | 248,837 |
| Equity | 488,735 | 804,086 | 1,125,862 | 1,674,998 | 2,054,045 | 2,047,899 | 2,206,246 | 1,519,735 |
| Liabilities | 214,546 | 124,458 | 135,357 | 119,496 | 125,529 | 139,867 | 260,702 | 337,769 |
| Non-current assets | 318,350 | 422,612 | 368,962 | 371,238 | 476,815 | 940,779 | 963,419 | 755,868 |
| Current assets | 381,858 | 500,585 | 879,861 | 1,419,303 | 1,712,947 | 1,243,906 | 1,497,709 | 1,089,503 |
| Total assets | 700,208 | 923,197 | 1,248,823 | 1,790,541 | 2,189,762 | 2,184,685 | 2,461,128 | 1,845,371 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 202,521 | 236,300 | 275,085 |
| Social insurance contributions | - | - | - | - | - | 191,984 | 213,375 | 241,620 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.1% | +14.2% | +7.9% | +30.3% | -1.0% | -3.3% | +5.6% | +19.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 47.1% | 59.9% | 44.6% | 37.2% | 17.3% | 0.1% | 6.4% | 13.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 67.4% | 68.8% | 49.5% | 39.8% | 18.5% | 0.1% | 7.2% | 16.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 25.1% | 36.9% | 34.5% | 31.7% | 18.2% | 0.1% | 7.4% | 9.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 28.9% | 41.4% | 40.2% | 36.8% | 21.1% | 1.1% | 8.5% | 11.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 60,533 | 61,527 | 65,919 | 90,489 | 86,758 | 78,733 | 72,903 | 75,768 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Panevėžio burnos chirurgijos centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-09-16 | 2021-10-11 | 0.01 |
Panevėžio burnos chirurgijos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-16 | 2026-01-16 | 533.45 |
| 2025-10-30 | 2025-11-21 | 0.49 |
| 2025-09-30 | 2025-10-24 | 3.49 |
| 2025-09-28 | 2025-09-29 | 3.65 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Panevežio burnos chirurgijos centras, UAB (code 302545792) is a private limited liability company engaged in dental practice care activities. In 2025, the company generated EUR 2.54 million in revenue, up 19.7% year on year and 26.3% compared with 2023. Net profit reached EUR 248.8 thousand, after EUR 158.3 thousand in 2024 and EUR 2.6 thousand in 2023, indicating a marked improvement in profitability over the three-year period. The 2025 profit margin was 9.8%. Return on equity stood at 16.4% and return on assets at 13.5%, while asset turnover was 1.38x. At the end of 2025, total assets were EUR 1.85 million, equity EUR 1.52 million and liabilities EUR 337.8 thousand. Compared with 2024, the balance sheet narrowed, as assets and equity declined while liabilities increased. The company still remained equity-intensive, with an equity ratio of 82.3% and debt-to-equity of 0.22. Revenue per employee was EUR 77.1 thousand and profit per employee EUR 7.5 thousand, showing solid operational productivity.